InvestDashboard.com



Meridian Bioscience, Inc. (VIVO)



$10.75
52 Week Low
$14.8
2017-04-28 15:03:43 MDT
$21.49
52 Week High

Basic Info

Healthcare
Sector
Diagnostic Substances
Industry
Nasdaq
Stock Exchange
United States
Country

Market Cap: $584,500,000Small Cap (Between $200M and $2B)
Analyst Recommendation:3.3Analysts say: Neutral-. (1=Strong Buy, 5=Strong Sell)
Beta: 0.65 Low Volatility Stock (beta under 1). Stock will go up less when the market goes up, and go down less when the market goes down. Beta of 1 means stock would match the S&P 500 Index.

Fundamentals

ForwardPE: 20.37
5 Yr Est Growth: 17.00%
Yield: 3.77%
PEG-Y Ratio: 0.98
Excellent Growth Value at a Reasonable Price! Company's growth plus yield is greater than or equal to the PE Ratio. PEGY less than 1 is Excellent!

Technicals

% Above 50 DayMA: 10.70%
% Above 200 DayMA: -4.15%
VIVO Performance 52 Weeks: -32.60%
S&P 500 Performance 52 Weeks: 13.50%
Mixed Trend. Short Term trend is up, but longer term trend is down. Currently beyond technical death cross because 50 Day MA is below 200 Day MA. Stock is closer to 52 Week Low than 52 Week High.
VIVO underperforming S&P 500 by -46.10% the last 52 Weeks.

Profile


More Valuation

Price To Book: 3.48
Great Value. Low Price to Book means better value.
EV to EBITDA: 10.18
Decent Value. A low EV to EBITDA ratio is great. Ideally, under 10. Under 17 is okay.

More Info

Field Value Average Comments
% Held By Insiders1.16% 17.28%Held by fewer than average Insiders.
% Held By Institutions91.10% 62.07%Institutional percentage greater than average. Institutional buying and selling can really move stock price.
Short % Of Float10.44% 07.02% Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards.
Debt to Equity0.35 1.08 More Conservative Financing. Each industry has different Debt/Equity standard. Higher than 1 means company is taking on more leverage.
Profit Margin %15.21%-00.18% Profit Margin is better than the average! Good job.
Operating Margin %25.69%-05.28% Operating Margin greater than average percent. Good.
Return on Equity %17.72%-08.79% Return on Equity greater than average percent. Good.
Return on Assets %14.33%-01.29% Return on Assets greater than average percent. Good.
Revenue Per Employee $299,584.62 $883,096.70 Less than average Revenue Per Employee. This stock (or industry) might not be as efficient as others? Each industry might have a different standard.
Price to Cash 12.65 5.52 Higher than average Price to Cash. Meaning that the company has a lower percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money.
CPEGY Ratio 0.90 2.26 Less than than average CPEGY Ratio. Ideally, a CPEGY should be less than 1 or less than 1.5. CPEGY is the PEG Ratio but incorporating the yield and subtracting Cash Per Share.

Quick Thoughts

PROS:
  1. Excellent PEGY (less than 1): 0.98

  2. Good 5 Yr Est Growth: 17.00%

  3. Above Avg Yield: 3.77%

  4. Stock is Above Short Term 50DMA: 10.70%

  5. Price to Book is under 5: 3.48

  6. Better than average EV/EBITDA: 10.18

  7. Profit Margin is positive: 15.21%

  8. Operating Margin is positively good: 25.69%

  9. Return on Equity is positive: 17.72%

  10. Return on Assets is positive: 14.33%

  11. Debt To Equity is lower than 1: 0.35

CONS:
  1. Analysts do not like this stock: 3.3 (1=Strong Buy, 5=Strong Sell)

  2. High Forward PE: 20.37

  3. Stock is Below Long Term 200DMA: -4.15%

  4. Stock underperforming S&P 500 over last 52 weeks: -46.10%

  5. Price to Cash Ratio (12.65) is greater than average. Company has less cash as a percent of price than the average.

  6. Shorted more than average: 10.44%


Headlines


Stock Chart


InvestDashboard.com VIVO: Meridian Bioscience, Inc.

This page updated Thu Feb 1 22:00:01 MST 2018.